Literature DB >> 25660553

Microbiota modulation of myeloid cells in cancer therapy.

Romina S Goldszmid1, Amiran Dzutsev2, Sophie Viaud3, Laurence Zitvogel3, Nicholas P Restifo4, Giorgio Trinchieri1.   

Abstract

Myeloid cells represent a major component of the tumor microenvironment, where they play divergent dual roles. They can induce antitumor immune responses, but mostly they promote immune evasion, tumor progression, and metastasis formation. Thus, strategies aiming at reprogramming the tumor microenvironment represent a promising immunotherapy approach. Myeloid cells respond to environmental factors including signals derived from commensal microbes. In this Cancer Immunology at the Crossroads overview, we discuss recent advances on the effects of the commensal microbiota on myeloid-cell functions and how they affect the response to cancer therapy. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25660553      PMCID: PMC4324508          DOI: 10.1158/2326-6066.CIR-14-0225

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  72 in total

Review 1.  Multiple facets of intestinal permeability and epithelial handling of dietary antigens.

Authors:  S Ménard; N Cerf-Bensussan; M Heyman
Journal:  Mucosal Immunol       Date:  2010-03-10       Impact factor: 7.313

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Microbiota regulates immune defense against respiratory tract influenza A virus infection.

Authors:  Takeshi Ichinohe; Iris K Pang; Yosuke Kumamoto; David R Peaper; John H Ho; Thomas S Murray; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

4.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells.

Authors:  Hsin-Jung Wu; Ivaylo I Ivanov; Jaime Darce; Kimie Hattori; Tatsuichiro Shima; Yoshinori Umesaki; Dan R Littman; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2010-06-25       Impact factor: 31.745

5.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

Authors:  Kiavash Movahedi; Damya Laoui; Conny Gysemans; Martijn Baeten; Geert Stangé; Jan Van den Bossche; Matthias Mack; Daniel Pipeleers; Peter In't Veld; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

6.  Direct translocation of staphylococci from the skin surface to deep organs.

Authors:  Beth L Hahn; Peter G Sohnle
Journal:  Microb Pathog       Date:  2013-06-05       Impact factor: 3.738

7.  A pathobiont of the microbiota balances host colonization and intestinal inflammation.

Authors:  Janet Chow; Sarkis K Mazmanian
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

8.  Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.

Authors:  Yun Kyung Lee; Juscilene S Menezes; Yoshinori Umesaki; Sarkis K Mazmanian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 9.  The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Authors:  Jérôme Galon; Helen K Angell; Davide Bedognetti; Francesco M Marincola
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  22 in total

1.  Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

Authors:  Chelsea Hope; Philip B Emmerich; Athanasios Papadas; Adam Pagenkopf; Kristina A Matkowskyj; Dana R Van De Hey; Susan N Payne; Linda Clipson; Natalie S Callander; Peiman Hematti; Shigeki Miyamoto; Michael G Johnson; Dustin A Deming; Fotis Asimakopoulos
Journal:  J Immunol       Date:  2017-07-28       Impact factor: 5.422

Review 2.  Monitoring immune responses in the tumor microenvironment.

Authors:  Jennifer A Wargo; Sangeetha M Reddy; Alexandre Reuben; Padmanee Sharma
Journal:  Curr Opin Immunol       Date:  2016-05-27       Impact factor: 7.486

Review 3.  Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Annu Rev Microbiol       Date:  2016-09-08       Impact factor: 15.500

Review 4.  ROS-modulated therapeutic approaches in cancer treatment.

Authors:  Muhammad Hassan Raza; Sami Siraj; Abida Arshad; Usman Waheed; Fahad Aldakheel; Shatha Alduraywish; Muhammad Arshad
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-24       Impact factor: 4.553

Review 5.  Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael W N Deininger; Jeffrey W Tyner; Eric Solary
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

Review 6.  Therapy-induced microenvironmental changes in cancer.

Authors:  Yuting Ma; Heng Yang; Jonathan M Pitt; Guido Kroemer; Laurence Zitvogel
Journal:  J Mol Med (Berl)       Date:  2016-03-02       Impact factor: 4.599

Review 7.  The role of microbiota in cancer therapy.

Authors:  Ernesto Perez-Chanona; Giorgio Trinchieri
Journal:  Curr Opin Immunol       Date:  2016-01-26       Impact factor: 7.486

8.  Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.

Authors:  Diwakar Davar; Amiran K Dzutsev; Giorgio Trinchieri; Hassane M Zarour; John A McCulloch; Richard R Rodrigues; Joe-Marc Chauvin; Robert M Morrison; Richelle N Deblasio; Carmine Menna; Quanquan Ding; Ornella Pagliano; Bochra Zidi; Shuowen Zhang; Jonathan H Badger; Marie Vetizou; Alicia M Cole; Miriam R Fernandes; Stephanie Prescott; Raquel G F Costa; Ascharya K Balaji; Andrey Morgun; Ivan Vujkovic-Cvijin; Hong Wang; Amir A Borhani; Marc B Schwartz; Howard M Dubner; Scarlett J Ernst; Amy Rose; Yana G Najjar; Yasmine Belkaid; John M Kirkwood
Journal:  Science       Date:  2021-02-05       Impact factor: 47.728

Review 9.  Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer.

Authors:  Bhagelu R Achyut; Ali S Arbab
Journal:  Onco Targets Ther       Date:  2016-03-01       Impact factor: 4.147

10.  The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells.

Authors:  Michal P Kuczma; Zhi-Chun Ding; Tao Li; Tsadik Habtetsion; Tingting Chen; Zhonglin Hao; Locke Bryan; Nagendra Singh; James N Kochenderfer; Gang Zhou
Journal:  Oncotarget       Date:  2017-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.